CSAD and type 2 diabetes mellitus: Based on the taurine metabolic pathway, CSAD is a crucial rate-limiting enzyme for the biosynthesis of taurine (Park et al., 2017), and its expression plays a pivotal role in the pathogenesis of T2DM in β-cells (Chen et al., 2021a).